dyslipidemia after kidney transplantation and correlation with cyclosporine level: a glimpse into the future
Authors
abstract
similar resources
Dyslipidemia After Kidney Transplantation and Correlation With Cyclosporine Level: A Glimpse into the Future
I read with interest the article by Hosseini et al. recently published in the Nephro-Urology Monthly, titled “dyslipidemia after kidney transplantation and correlation with cyclosporine level”. They concluded that dyslipidemia is common finding after kidney transplantation and has no correlation with Cyclosporine level (1). Importantly, serum creatinine was the only risk factor for hypercholest...
full textdyslipidemia after kidney transplantation and correlation with cyclosporine level
conclusions dyslipidemia is a common finding after kidney transplantation and has no correlation with csa level. according to conflicting data on the precise effect of different factors in inducing dyslipidemia, prospective large sample size studies should consider better control of dyslipidemia. results mean age of 1391studied population was 38.7 ± 15 years old. hypercholesterolemia and hypert...
full textDyslipidemia After Kidney Transplantation and Correlation With Cyclosporine Level
BACKGROUND Dyslipidemia after kidney transplantation is a frequent finding and is multifactorial. Immunosuppressive agents such as cyclosporine (CsA) can cause hypercholesterolemia. OBJECTIVES As there were few reports with conflicting evidence on whether CsA related dyslipidemia is dose related and that CsA monitoring assays (trough level, C0, or two hour post dose level, C2) is a better pre...
full textThe Relationship between the Plasma Level of Cyclosporine-A and Drug Dose in Patients of Kermanshah Kidney Transplantation Center
Background: Nowadays the main problem in transplantation is the complexity of host immune system protection against the immunological and destructive reactions of the transplanted organ. High serum level of the immunosuppressive drug may cause toxicity and low serum level leads to the rejection of the transplanted organ. Cyclosporine has been known as the most effective immunosuppressive drug. ...
full textKidney transplantation: into the future with belatacept
Allogenic organ transplantations are limited by drug-associated toxicity and the occurrence of antibody-mediated rejection or chronic rejection. The development of immunosuppressants that have minimal adverse and nephrotoxic effects is important to improve outcomes after organ transplantation. Several promising new compounds, based on our improved understanding of the molecular mechanisms of re...
full textA glimpse into the future.
Prostate cancer has become a major public health problem worldwide. In both highand low-risk populations, rates are increasing; clearly some of the increase is related to the widespread use of prostate-specific antigen (PSA) testing in developed countries. Among US men, it is the most commonly diagnosed non-skin cancer and the second most common cause of cancer deaths. Despite its substantial m...
full textMy Resources
Save resource for easier access later
Journal title:
nephro-urology monthlyجلد ۵، شماره ۵، صفحات ۱۰۰۶-۱۰۰۷
Keywords
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023